LABU Holdings Information

LABU is an equity ETF with a total of 168 individual holdings.

Total Holdings

168

Top 10 Percentage

51.19%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

556.88M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	16.59%	94,597,435
2	n/a	Goldman Finl Sq Trsry Inst 506	12.02%	68,511,957
3	n/a	Goldman Sachs Fin Gov 465 Institut	11.43%	65,181,150
4	n/a	S&P Biotechnology Select Industry Index Swap	2.55%	25,717
5	n/a	S&P Biotechnology Select Industry Index Swap	2.18%	29,608
6	n/a	Cash	1.75%	9,966,245
7	n/a	S&P Biotechnology Select Industry Index Swap	1.29%	48,261
8	MRNA	Moderna, Inc.	1.27%	140,309
9	n/a	S&P Biotechnology Select Industry Index Swap	1.09%	15,532
10	ROIV	Roivant Sciences Ltd.	1.01%	201,245
11	PCVX	Vaxcyte, Inc.	0.99%	93,658
12	ACLX	Arcellx, Inc.	0.97%	48,671
13	RVMD	Revolution Medicines, Inc.	0.94%	52,303
14	PRAX	Praxis Precision Medicines, Inc.	0.93%	15,572
15	FOLD	Amicus Therapeutics, Inc.	0.87%	345,245
16	AMGN	Amgen Inc.	0.86%	12,916
17	GILD	Gilead Sciences, Inc.	0.85%	33,567
18	MIRM	Mirum Pharmaceuticals, Inc.	0.83%	51,075
19	KRYS	Krystal Biotech, Inc.	0.82%	16,991
20	BMRN	BioMarin Pharmaceutical Inc.	0.81%	75,850
21	HALO	Halozyme Therapeutics, Inc.	0.79%	65,013
22	CELC	Celcuity Inc.	0.78%	39,999
23	VRTX	Vertex Pharmaceuticals Incorporated	0.77%	9,159
24	EXEL	Exelixis, Inc.	0.77%	99,178
25	ALKS	Alkermes plc	0.77%	142,320

Showing 25 of 168 holdings

Subscribe to see the full list

As of Feb 25, 2026